BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38258487)

  • 1. NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass.
    Larion S; Padgett CA; Mintz JD; Thompson JA; Butcher JT; Belin de Chantemèle EJ; Haigh S; Khurana S; Fulton DJ; Stepp DW
    Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G264-G273. PubMed ID: 38258487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
    Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
    Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1.
    Padgett CA; Bátori RK; Speese AC; Rosewater CL; Bush WB; Derella CC; Haigh SB; Sellers HG; Corley ZL; West MA; Mintz JD; Ange BB; Harris RA; Brands MW; Fulton DJR; Stepp DW
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):e381-e395. PubMed ID: 37586054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing muscle mass improves vascular function in obese (db/db) mice.
    Qiu S; Mintz JD; Salet CD; Han W; Giannis A; Chen F; Yu Y; Su Y; Fulton DJ; Stepp DW
    J Am Heart Assoc; 2014 Jun; 3(3):e000854. PubMed ID: 24965025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.
    Matsumoto M; Zhang J; Zhang X; Liu J; Jiang JX; Yamaguchi K; Taruno A; Katsuyama M; Iwata K; Ibi M; Cui W; Matsuno K; Marunaka Y; Itoh Y; Torok NJ; Yabe-Nishimura C
    Free Radic Biol Med; 2018 Feb; 115():412-420. PubMed ID: 29274380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone.
    Ali MI; Ketsawatsomkron P; Belin de Chantemele EJ; Mintz JD; Muta K; Salet C; Black SM; Tremblay ML; Fulton DJ; Marrero MB; Stepp DW
    Circ Res; 2009 Nov; 105(10):1013-22. PubMed ID: 19797171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Deletion of NADPH Oxidase 1 Rescues Microvascular Function in Mice With Metabolic Disease.
    Thompson JA; Larion S; Mintz JD; Belin de Chantemèle EJ; Fulton DJ; Stepp DW
    Circ Res; 2017 Aug; 121(5):502-511. PubMed ID: 28684629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1.
    Yamamoto A; Takeya R; Matsumoto M; Nakayama KI; Sumimoto H
    FEBS J; 2013 Oct; 280(20):5145-59. PubMed ID: 23957209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm.
    Larion S; Padgett CA; Butcher JT; Mintz JD; Fulton DJ; Stepp DW
    Am J Physiol Gastrointest Liver Physiol; 2022 Oct; 323(4):G387-G400. PubMed ID: 35997288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1.
    Miyano K; Ueno N; Takeya R; Sumimoto H
    J Biol Chem; 2006 Aug; 281(31):21857-21868. PubMed ID: 16762923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The involvement of NOX1/NADPH oxidase in the development of non-alcoholic steatohepatitis].
    Matsumoto M
    Nihon Yakurigaku Zasshi; 2018; 152(4):181-186. PubMed ID: 30298839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.
    Kawahara T; Ritsick D; Cheng G; Lambeth JD
    J Biol Chem; 2005 Sep; 280(36):31859-69. PubMed ID: 15994299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
    Lan T; Kisseleva T; Brenner DA
    PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 inhibits interferon gamma- and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon.
    Kamizato M; Nishida K; Masuda K; Takeo K; Yamamoto Y; Kawai T; Teshima-Kondo S; Tanahashi T; Rokutan K
    J Gastroenterol; 2009; 44(12):1172-84. PubMed ID: 19714290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity.
    Muñoz M; López-Oliva ME; Rodríguez C; Martínez MP; Sáenz-Medina J; Sánchez A; Climent B; Benedito S; García-Sacristán A; Rivera L; Hernández M; Prieto D
    Redox Biol; 2020 Jan; 28():101330. PubMed ID: 31563085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
    Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
    Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population.
    Rabelo F; Stefano JT; Cavaleiro AM; Lima RVC; de Campos Mazo DF; Carrilho FJ; Correa-Giannella ML; Oliveira CP
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):330-335. PubMed ID: 30087027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.